10-Year Benefit With FFR-Guided Complete Revascularization for STEMI

10-Year Benefit With FFR-Guided Complete Revascularization for STEMI

(MedPage Today) -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization has clinical benefits. At...

Cordis Initiates SELUTION Global Coronary Registry - Cardiac Interventions Today

May 19, 2025—Cordis announced the initiation of the SELUTION Global Coronary Registry. According to the company, the prospective study will enroll up to 10,000 patients worldwide to track real-world outcomes of Selution SLR, a sirolimus drug-eluting balloon (DEB) with sustained limus release (SLR), for up to 5 years. Cordis stated that the findings will complement the results from the five ongoing level-1 randomized trials of the Selution SLR DE…

Cordis launches 10,000-patient registry for drug-eluting balloon

The Selution SLR drug-eluting balloon. [Image courtesy of Cordis]Cordis today announced the initiation of a global registry to track real-world outcomes for the Selution SLR drug-eluting balloon (DEB). Miami Lakes, Florida-based Cordis expects the SELUTION Global Coronary Registry to enroll up to 10,000 patients worldwide. It says that would make it one of the largest coronary DEB registries to date. Investigators plan to track real-world outcom…